Marcadia inks development deal with Merck
Indianapolis startup Marcadia Biotech Inc. today announced it has signed an agreement with drug giant Merck & Co. Inc. to help bring Marcadia’s promising diabetes therapies to market. Financial terms were not disclosed. However, Merck, headquartered in Whitehouse Station, N.J., will pay Marcadia an upfront fee as well as payments for exclusivity and ongoing collaborative […]